Nurix Therapeutics: Of This Current Report On Form 8k Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liability Of That Section, And Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Filed Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Be Expressly Set Forth By Specific Reference In Such Filing. In Addition, The Information Set Forth Under This Item 7.01, Including Exhibits 99.1 And 99.2, Shall Not Be Deemed An Admission As To The Materiality Of Any Information In This Current Report On Form 8k, Other Events, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Nurix Therapeutics Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***